Guiyang, Guian introduce 27 health, pharmaceutical projects

Guiyang and Guian New Area in Southwest China's Guizhou province have become the site of 27 health and pharmaceutical projects this year, with a total investment of 7.65 billion yuan ($1.08 billion) and 2.36 billion yuan of funds in place.

Among the highlights are the medical industrial park invested by China National Pharmaceutical Group Co., Ltd (Sinopharm), a medical device and pharmaceutical production base, and a China medical device Guizhou headquarters base.

In recent years, Guiyang has been focusing on boosting business promotion in the medical field and has achieved strong results.

Yipin (Guiyang) Quality Technology Co, which set up operations in the city's Baiyun district in November 2019, has set an example of how a medical enterprise can develop in Guiyang.

The company is mainly engaged in the research and development of new mid-to-high-end medical devices and biological materials, and provides one-stop services such as R&D outsourcing, inspection and testing, product safety and performance evaluation, international certification, commercialization of scientific and technological achievements, and venture capital services.

The company has built a medical consumable testing center as well as a medical biomaterial research, development and analysis platform, with a project investment of 100 million yuan.

Its R&D outsourcing industry chain of medical devices covers more than 200 categories and serves 3,000 enterprises, and its market network extends from the Yangtze River Delta to Southwest China, South China, North China, and Central China.